chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, White blood cell count normal
Clinical narrative: presented with altered mental status and SOB; positive for COVID-19 pneumonia;CXR revealed bilateral opacities subjectively they are mild in nature. admitted to the hospital and was noted to have drop in oxygen saturation up to 86% on ambulation. Labs: D-Dimer was negative, serum WBC negative, lactic unremarkable.  CRP 6.35, Procal 0.07  Tx: IV dexamethasone and remdesivir, also rec'd maxipine, Vit C, Lovenox, Singulair, and zind.  His oxygenation has improved;  room air at d/c.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Computerised tomogram normal, Dyspnoea, Encephalopathy
Clinical narrative: Presented with SOB; previous covid exposure; Covid + in ED; CXR and CT without PNA; Tx: Remdesivir, Decadron, Vit C, Zinc, antibiotics, lovenox, Vit D3, singulair;  had encephalopathy due to covid; improving at d/c; on room air at time of d/c
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2, SARS-CoV-2 test positive
Clinical narrative: Presented with SOB; previous covid exposure; Covid + in ED; CXR and CT without PNA; Tx: Remdesivir, Decadron, Vit C, Zinc, antibiotics, lovenox, Vit D3, singulair;  had encephalopathy due to covid; improving at d/c; on room air at time of d/c
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Overdose, SARS-CoV-2 test positive
Clinical narrative: Hospitalization for calcium channel blocker overdose (COVID-19 positive three days later) on dates 8/7/2023-9/4/2023. Treated with dexamethasone, baricitinib, Remdesivir, vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Age: 8.0
Sex: M
Vaccine: HEPA
Symptoms: Fall, Head injury, Syncope
Clinical narrative: 5 minutes after vaccination he stood up, climbed down from exam table and had a syncopal episode, falling forward and striking his left temple. He recovered consciousness quickly, rested, no concussion or other serious injury resulted.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19 pneumonia
Clinical narrative: Hospitalization for acute hypoxic respiratory failure secondary to COVID PNA with concern for superimposed bacterial community-acquired pneumonia on dates 8/29/2023- 9/1/2023. Treated with dexamethasone, Remdesivir, vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Age: 71.0
Sex: F
Vaccine: RSV
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 48.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient was given the second dose of monkeypox vaccine that had expired 8/31/2023. No symptoms reported.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Back pain, Musculoskeletal pain, Pruritus, Rash erythematous, Rash papular
Clinical narrative: day 2 after immunization, pt reports pain to lower back/upper buttocks. Red raised bumps noted with intense itch  1/2 inch x 1 inch area. No neuralgia pain noted.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Biopsy bladder, Bladder cancer, Bladder operation, Chemotherapy, Computerised tomogram
Clinical narrative: Eleven months after the first vaccine I was diagnosed with MIBC, muscle invasive bladder cancer.  Treatment was about 15 days of chemo, Cisplatin and etoposide. About 35 days of bladder radiation and 6 treatments of BCG.  Six or eight surgeries to remove/scrape bladder in city and/or city and take biopsies. Currently cancer free but in surveillance treatment every three months which involves cystoscope and CT scans.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cystoscopy, Intravesical immunotherapy, Laboratory test, Radiotherapy
Clinical narrative: Eleven months after the first vaccine I was diagnosed with MIBC, muscle invasive bladder cancer.  Treatment was about 15 days of chemo, Cisplatin and etoposide. About 35 days of bladder radiation and 6 treatments of BCG.  Six or eight surgeries to remove/scrape bladder in city and/or city and take biopsies. Currently cancer free but in surveillance treatment every three months which involves cystoscope and CT scans.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE
Age: 69.0
Sex: F
Vaccine: RSV, RSV
Symptoms: Injection site bruising, Injection site swelling, Pyrexia
Clinical narrative: large bruise at injection site for approximately 2 weeks and not resolving, consistent fever and swelling at injection site
Age: 69.0
Sex: F
Vaccine: RSV, RSV
Symptoms: Injection site pain, Injection site swelling, Injection site warmth, Wound
Clinical narrative: large bruise at injection site for approximately 2 weeks and not resolving, consistent fever and swelling at injection site
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE
Age: 71.0
Sex: F
Vaccine: COVID19-2, COVID19
Symptoms: Pruritus, Skin abrasion, Skin haemorrhage, Urticaria
Clinical narrative: Client received Pfizer Bivalent Booster on 8/28/23. She called clinic stating that on 8/29/23 she noticed hives on both arms that itch so badly she has caused her self to bleed from scratching. She has tried over the counter benadryl and hydrocortisone creams. This is her 5th COVID vaccine and 2nd Bivalent Pfizer. First bivalent booster was a multidose vial and second bivalent booster was a Singledose vial. Client has a long history of allergies to medications.
Age: 71.0
Sex: F
Vaccine: COVID19-2, COVID19
Symptoms: Hypersensitivity
Clinical narrative: Client received Pfizer Bivalent Booster on 8/28/23. She called clinic stating that on 8/29/23 she noticed hives on both arms that itch so badly she has caused her self to bleed from scratching. She has tried over the counter benadryl and hydrocortisone creams. This is her 5th COVID vaccine and 2nd Bivalent Pfizer. First bivalent booster was a multidose vial and second bivalent booster was a Singledose vial. Client has a long history of allergies to medications.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE
Age: 16.0
Sex: F
Vaccine: MNQ
Symptoms: Dizziness, Nausea, Visual impairment, Vomiting
Clinical narrative: Patient became dizzy and nauseated after vaccination. Patient c/o not being able to see clearly. Feet propped in chair. Cool air and cool paper towels placed on neck and face. Patient vomited approximately 50-100 ccs. Stated that she felt better after vomiting. Coke and crackers given. After approximately 10 mins patient felt better and was able to ambulate to lobby with dad. Dad is a physician assistant. Advised dad to wait in lobby an additional 10-15 mins before they leave. Dad voiced understanding. Copy of immunization records given. Reviewed possible side effects of immunization(s). Advised for patient to wait in lobby for 20 mins after shot(s) to monitor for reaction.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE
Age: 96.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Covid-19 Breakthrough Infection
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Covid-19 Breakthrough Infection
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Feeling abnormal, Lethargy, Migraine, Myalgia, Toothache
Clinical narrative: Migraine headache which I typically don't experience. Teeth pain/ache, muscle aches Mentally fuzzy and overall experiencing mild lethargy. I'm able to continue with my day at work but would rather be resting.
Age: 99.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Hepatic enzyme increased, Loss of consciousness, Lymphocyte count increased
Clinical narrative: 5 days after receiving my first dose of the vaccine I passed out, had elevated blood pressure (with no past history) of 157/91, elevated liver enzymes, and elevated lymphocytes
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE
Age: 24.0
Sex: M
Vaccine: HEP
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No adverse effects.  Administration error. Pt. was given a pediatric dose instead of adult dose. An adult dose was administered later that day.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Breath sounds abnormal, Dyspnoea, Secretion discharge, Swelling of eyelid, Urticaria
Clinical narrative: Patient received the vaccines at 0927 AM in the clinic for no adverse effects. Patient's mother called the clinic at 10:24 AM stating that the patient's eyes were swollen shut and he had developed hives. She was advised to seek immediate emergency care. When he arrived at the ER he had increased work of breathing and noisy breathing with increased secretions. He was given epinephrine and monitored for several hours for improved symptoms. He was discharged home from the ER in stable condition.
Age: 60.0
Sex: M
Vaccine: COVID19-2
Symptoms: Product storage error
Clinical narrative: Patient received a vaccine that was removed from the refrigerator on 9/1/2023 and was left at room temperature until it was administered on 9/5/2023
Age: 9.0
Sex: M
Vaccine: MMR, MNQ, TDAP, VARCEL
Symptoms: Inappropriate schedule of product administration
Clinical narrative: vaccine not required at the time
Age: 12.0
Sex: F
Vaccine: COVID19-2, HEP, HEPA, HPV9, MNQ, TDAP
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: On 09/05/2023, one dose of Pfizer-BioNtech Covid-19 vaccine, Bivalent Ages 5 to <12y , 0.2mL was administered intramuscularly to the patient who turned 12 years old  on 08/30/2023.   Patient did not exhibit signs and symptoms of an adverse reaction.
Age: 53.0
Sex: M
Vaccine: VARZOS
Symptoms: Lumbar puncture normal, Magnetic resonance imaging head, Magnetic resonance imaging head normal, Magnetic resonance imaging spinal normal, Magnetic resonance imaging thoracic normal
Clinical narrative: Wall-eyed bilateral internuclear ophthalmoplegia syndrome.
Age: 53.0
Sex: M
Vaccine: VARZOS
Symptoms: Ophthalmoplegia
Clinical narrative: Wall-eyed bilateral internuclear ophthalmoplegia syndrome.
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Product storage error
Clinical narrative: Patient received covid vaccination on 9/5/2023 from a vial that was removed from the refrigerator on 9/1/2023 and sat at room temperature for 4 days.  Vaccine was no longer viable at time of administration
Age: 1.08
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: child received a bivalent COVID immunization vaccine clinic. The dose received was not correct and may not adequately protect against COVID.  No adverse event reported.
Age: 0.58
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: No physical adverse reaction, documenting for vaccine error that PedvaxHib administered when it was not due.
Age: 87.0
Sex: F
Vaccine: RSV
Symptoms: Injection site pruritus, Injection site reaction, Injection site warmth
Clinical narrative: Patient shows signs of injection site reaction. States that it is warm to the touch and itchy. Patient went to her primary care was told to apply warm compress, and given prescription.
Age: 1.92
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: child received a bivalent COVID immunization at vaccine clinic. The dose received was not correct and may not adequately protect against COVID.  No adverse event reported.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine stored in an unapproved storage unit
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Drooling, Electroencephalogram, Epilepsy, Fall
Clinical narrative: She got her vaccine, and seemed fine until June 8, 2022 when all of a sudden her mother heard a weird noise in her room, she went in and saw her gripping her chair with one hand, and her other hand in her hair (she has witnessed her aunt having seizures), and she knew to get her down on the bed.  She had incontinence, on her side and had to wait for the seizure to subside.  She then called EMS and had drooling and had to clean her up.  They took her to Hospital, Dr., who saw her and did MRI's, blood work, and other testing.  They never told them that she had anything on her head or anything.  Then she went to the pediatrician's office and they did an EEG as well.  They said that she had epilepsy which she had never had before.  Then in September of 2022 she had another seizure as she was not taking her medications that she was prescribed.  She fell at school and had a knot on her head.  She continues to take her medicine and has not had any more.  They redid her EEG in June of 2023 and it is clear.  She takes Keepra 500 mg twice a day.  If she has to take an attitude she has to take Vitamins and she has emergency medication which is a nasal spray for her epilepsy (Nayzilam).  They have changed schools, and is doing better now that she has.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Head injury, Incontinence, Magnetic resonance imaging, Seizure
Clinical narrative: She got her vaccine, and seemed fine until June 8, 2022 when all of a sudden her mother heard a weird noise in her room, she went in and saw her gripping her chair with one hand, and her other hand in her hair (she has witnessed her aunt having seizures), and she knew to get her down on the bed.  She had incontinence, on her side and had to wait for the seizure to subside.  She then called EMS and had drooling and had to clean her up.  They took her to Hospital, Dr., who saw her and did MRI's, blood work, and other testing.  They never told them that she had anything on her head or anything.  Then she went to the pediatrician's office and they did an EEG as well.  They said that she had epilepsy which she had never had before.  Then in September of 2022 she had another seizure as she was not taking her medications that she was prescribed.  She fell at school and had a knot on her head.  She continues to take her medicine and has not had any more.  They redid her EEG in June of 2023 and it is clear.  She takes Keepra 500 mg twice a day.  If she has to take an attitude she has to take Vitamins and she has emergency medication which is a nasal spray for her epilepsy (Nayzilam).  They have changed schools, and is doing better now that she has.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine stored in unapproved storage unit
Age: 1.17
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: child received a bivalent COVID immunization at vaccine clinic. The dose received was not correct and may not adequately protect against COVID.  No adverse event reported.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine stored in an unapproved storage unit
Age: 0.75
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: child received a bivalent COVID immunization at vaccine clinic. The dose received was not correct and may not adequately protect against COVID.  No adverse event reported.
Age: 60.0
Sex: M
Vaccine: YF
Symptoms: Chills, Oral herpes, Pain
Clinical narrative: Client stated that about a week after vaccination her started developing a fever, T-Max 100, body aches, chills, and developed some cold sores.  Taking tylenol and this does bring the fever down and helps with symptoms.
Age: 1.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Child received a bivalent COVID immunization at vaccine clinic. The dose received was not correct and may not adequately protect against COVID.  No adverse effects were reported at this time.
Age: 0.83
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: child received a bivalent COVID immunization at vaccine clinic. The dose received was not correct and may not adequately protect against COVID.  No adverse event reported.
Age: 0.67
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: child received a bivalent COVID immunization at vaccine clinic. The dose received was not correct and may not adequately protect against COVID.  No adverse event reported.
Age: 2.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Child received a bivalent COVID immunization at vaccine clinic. The dose received was not correct and may not adequately protect against COVID.  No adverse effects reported at this time.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: First, this form is WAY to cumbersome to expect many lay people to fill out before getting to the point.  After getting the second of the three COVID vaccines I am one of the people who developed TINNITUS. It is ONGOING. I hear it more in the left ear than my right.
Age: 2.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Child received a bivalent COVID immunization at vaccine clinic. The dose received was not correct and may not adequately protect against COVID.   No adverse effects reported at this time.
Age: 1.33
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: child received a bivalent COVID immunization at vaccine clinic. The dose received was not correct and may not adequately protect against COVID.  No adverse event reported.
Age: 1.42
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: child received a bivalent COVID immunization at vaccine clinic. The dose received was not correct and may not adequately protect against COVID.  No adverse event reported.
Age: 62.0
Sex: M
Vaccine: UNK
Symptoms: Expired product administered, No adverse event
Clinical narrative: No reactions, no symptoms. Patient tolerated vaccine well but vaccine administered was expired by almost 3 months.
Age: 0.92
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: child received a bivalent COVID immunization at vaccine clinic. The dose received was not correct and may not adequately protect against COVID.  No adverse event reported.
Age: 1.92
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Child received a bivalent COVID immunization at vaccine clinic. The dose received was not correct and may not adequately protect against COVID.   No adverse effects reported at this time.
Age: 1.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: child received a bivalent COVID immunization at vaccine clinic. The dose received was not correct and may not adequately protect against COVID.  No adverse event reported.
Age: 3.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: child received a bivalent COVID immunization at vaccine clinic. The dose received was not correct and may not adequately protect against COVID.  No adverse event reported.
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Child received a bivalent COVID immunization at vaccine clinic. The dose received was not correct and may not adequately protect against COVID.   No adverse effects reported at this time.
Age: 16.0
Sex: M
Vaccine: HPV9
Symptoms: Extra dose administered, No adverse event, Wrong patient received product, Wrong product administered
Clinical narrative: Patient presented for an appt with his sister.  Patient had already completed his series of HPV vaccine and was due for his #2 Menveo and #1 Bexsero  Staff accidentally administered his sister's HPV vaccine to him and vice versa.  No adverse reactions noted.  Patient will need to return for correct vaccinations.
Age: 0.83
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Child received a bivalent COVID immunization at vaccine clinic. The dose received was not correct and may not adequately protect against COVID.   No adverse effects reported at this time.
Age: 1.17
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Child received a bivalent COVID immunization at vaccine clinic. The dose received was not correct and may not adequately protect against COVID.   No adverse effects reported at this time.
Age: 1.25
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Child received a bivalent COVID immunization at vaccine clinic. The dose received was not correct and may not adequately protect against COVID.   No adverse effects reported at this time.
Age: 0.5
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Child received a bivalent COVID immunization at vaccine clinic. The dose received was not correct and may not adequately protect against COVID.   No adverse effects reported at this time.
Age: 12.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Patient came into clinic with brother for Child Health.  Patient was due for #2 HPV.  Patient was given her brother's vaccines instead and received a #2 Menveo-had first at age 11 and a Bexsero.  No adverse reactions noted.  Patient was scheduled back to receive correct vaccine.
Age: 0.58
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Child received a bivalent COVID immunization at vaccine clinic. The dose received was not correct and may not adequately protect against COVID.   No adverse effects reported at this time.
Age: 60.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Dermatitis allergic, Hypersensitivity, Rash
Clinical narrative: Patient woke up this morning with a rash on his forehead. He describes it as an allergic reaction type of rash. It does not itch.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, C-reactive protein increased, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 6/5/2023 Discharge Date: 6/8/2023   Clinical Narrative:   The patient is a 58-year-old gentleman whose mother law was in a local skilled nursing facility where she was exposed to in developed COVID pneumonia.  The patient's wife was visiting her mother and did not mask.  She promptly developed COVID pneumonia and subsequently exposed this chronically immunosuppressed patient.  He developed COVID pneumonia was admitted through the emergency room with hypoxemia.  He was treated with IV Decadron given the hypoxia and received remdesivir given the symptomatic nature of his presentation, his need for hospitalization, and for the purposes of preventing progression to worsening disease or potential intensive care unit care or ventilator need.  He responded quite quickly and was stable on room air the following evening.  Remdesivir and Decadron continued.  He was significantly hyperglycemic and Decadron was subsequently decrease, somewhat.  The patient has had 4 days of remdesivir today.  Should he does meet criteria for a three-day the discharge but we were still working with better blood sugar control and electrolyte management yesterday.  He prefers to go home today rather than extending his stay through the 5th day of remdesivir therapy, again, given his candidacy for early termination of the remdesivir therapy.  Pneumonia due to COVID-19 virus Assessment & Plan   COVID-19 pneumonia with hypoxemia.  His result of the hypoxemia, Decadron 6 mg IV daily has been added.  As result the dyspnea and hypoxia, he will be treated with remdesivir per protocol.  Hope to avoid progression by so doing.   Serial CRP and D-dimers.  A perfusion lung scan was ordered.  Lower extremity venous Doppler study ordered and pending.  Will consider concurrent treatment with azithromycin and empiric coverage for community-acquired pneumonia, though suspect his hypoxia at present, is COVID related.   06/06/2023   - bilateral lower extremity venous Doppler study negative.  Nuclear medicine perfusion/pulmonary study pending this a.m.   06/07/2023   - oxygenation improved.  Off of supplemental O2.  Repeat chest x-ray quite stable.  Infiltrates have resolved.  Had considered stopping remdesivir at day 3. His CRP and D dimer however remain high.  He is fully anticoagulated at present.  Will proceed with nuclear medicine perfusion lung scan.   06/08/2023   - doing well. O2 needs at baseline for several days now and on room air. Will discuss whether to finish the Remdesivir or stop at day 3-4... risk/benefit with patient...                         - discussed with the patient.  He is doing well.  He has no shortness of breath.  He has no cough.  He is ambulating well without difficulty.  He would like to be discharged home and this should be safe at this juncture.  Impression like to limit his duration of corticosteroid exposure and the duration of remdesivir exposure given his immunosuppressed state with his renal transplant and cyclosporine.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Diabetes mellitus management, Dyspnoea, Exposure to SARS-CoV-2, Fibrin D dimer increased
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 6/5/2023 Discharge Date: 6/8/2023   Clinical Narrative:   The patient is a 58-year-old gentleman whose mother law was in a local skilled nursing facility where she was exposed to in developed COVID pneumonia.  The patient's wife was visiting her mother and did not mask.  She promptly developed COVID pneumonia and subsequently exposed this chronically immunosuppressed patient.  He developed COVID pneumonia was admitted through the emergency room with hypoxemia.  He was treated with IV Decadron given the hypoxia and received remdesivir given the symptomatic nature of his presentation, his need for hospitalization, and for the purposes of preventing progression to worsening disease or potential intensive care unit care or ventilator need.  He responded quite quickly and was stable on room air the following evening.  Remdesivir and Decadron continued.  He was significantly hyperglycemic and Decadron was subsequently decrease, somewhat.  The patient has had 4 days of remdesivir today.  Should he does meet criteria for a three-day the discharge but we were still working with better blood sugar control and electrolyte management yesterday.  He prefers to go home today rather than extending his stay through the 5th day of remdesivir therapy, again, given his candidacy for early termination of the remdesivir therapy.  Pneumonia due to COVID-19 virus Assessment & Plan   COVID-19 pneumonia with hypoxemia.  His result of the hypoxemia, Decadron 6 mg IV daily has been added.  As result the dyspnea and hypoxia, he will be treated with remdesivir per protocol.  Hope to avoid progression by so doing.   Serial CRP and D-dimers.  A perfusion lung scan was ordered.  Lower extremity venous Doppler study ordered and pending.  Will consider concurrent treatment with azithromycin and empiric coverage for community-acquired pneumonia, though suspect his hypoxia at present, is COVID related.   06/06/2023   - bilateral lower extremity venous Doppler study negative.  Nuclear medicine perfusion/pulmonary study pending this a.m.   06/07/2023   - oxygenation improved.  Off of supplemental O2.  Repeat chest x-ray quite stable.  Infiltrates have resolved.  Had considered stopping remdesivir at day 3. His CRP and D dimer however remain high.  He is fully anticoagulated at present.  Will proceed with nuclear medicine perfusion lung scan.   06/08/2023   - doing well. O2 needs at baseline for several days now and on room air. Will discuss whether to finish the Remdesivir or stop at day 3-4... risk/benefit with patient...                         - discussed with the patient.  He is doing well.  He has no shortness of breath.  He has no cough.  He is ambulating well without difficulty.  He would like to be discharged home and this should be safe at this juncture.  Impression like to limit his duration of corticosteroid exposure and the duration of remdesivir exposure given his immunosuppressed state with his renal transplant and cyclosporine.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperglycaemia, Hypoxia, Lung infiltration, Pneumonia, Ultrasound Doppler normal
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 6/5/2023 Discharge Date: 6/8/2023   Clinical Narrative:   The patient is a 58-year-old gentleman whose mother law was in a local skilled nursing facility where she was exposed to in developed COVID pneumonia.  The patient's wife was visiting her mother and did not mask.  She promptly developed COVID pneumonia and subsequently exposed this chronically immunosuppressed patient.  He developed COVID pneumonia was admitted through the emergency room with hypoxemia.  He was treated with IV Decadron given the hypoxia and received remdesivir given the symptomatic nature of his presentation, his need for hospitalization, and for the purposes of preventing progression to worsening disease or potential intensive care unit care or ventilator need.  He responded quite quickly and was stable on room air the following evening.  Remdesivir and Decadron continued.  He was significantly hyperglycemic and Decadron was subsequently decrease, somewhat.  The patient has had 4 days of remdesivir today.  Should he does meet criteria for a three-day the discharge but we were still working with better blood sugar control and electrolyte management yesterday.  He prefers to go home today rather than extending his stay through the 5th day of remdesivir therapy, again, given his candidacy for early termination of the remdesivir therapy.  Pneumonia due to COVID-19 virus Assessment & Plan   COVID-19 pneumonia with hypoxemia.  His result of the hypoxemia, Decadron 6 mg IV daily has been added.  As result the dyspnea and hypoxia, he will be treated with remdesivir per protocol.  Hope to avoid progression by so doing.   Serial CRP and D-dimers.  A perfusion lung scan was ordered.  Lower extremity venous Doppler study ordered and pending.  Will consider concurrent treatment with azithromycin and empiric coverage for community-acquired pneumonia, though suspect his hypoxia at present, is COVID related.   06/06/2023   - bilateral lower extremity venous Doppler study negative.  Nuclear medicine perfusion/pulmonary study pending this a.m.   06/07/2023   - oxygenation improved.  Off of supplemental O2.  Repeat chest x-ray quite stable.  Infiltrates have resolved.  Had considered stopping remdesivir at day 3. His CRP and D dimer however remain high.  He is fully anticoagulated at present.  Will proceed with nuclear medicine perfusion lung scan.   06/08/2023   - doing well. O2 needs at baseline for several days now and on room air. Will discuss whether to finish the Remdesivir or stop at day 3-4... risk/benefit with patient...                         - discussed with the patient.  He is doing well.  He has no shortness of breath.  He has no cough.  He is ambulating well without difficulty.  He would like to be discharged home and this should be safe at this juncture.  Impression like to limit his duration of corticosteroid exposure and the duration of remdesivir exposure given his immunosuppressed state with his renal transplant and cyclosporine.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine stored in an unapproved storage unit
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine stored in an unapproved storage unit
Age: 12.0
Sex: M
Vaccine: IPV, MMRV, PPV
Symptoms: Expired product administered, No adverse event
Clinical narrative: When charting the PPV23 vaccine I noted that the vaccine had expired on 8/29/23.  For some reason this dose was mixed in with the other PPV23 vaccines that expire on 10/1/23.  Pt. tolerated the injection without incident and no adverse event was noted or reported.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test normal, Cardiac monitoring normal, Condition aggravated, Fatigue, Palpitations
Clinical narrative: Racing heart - 48 hour monitor showed no events, fatigue - blood test showed no adverse effects, kidney - acute kidney disease. none of the health care providers can find a solution.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Renal disorder
Clinical narrative: Racing heart - 48 hour monitor showed no events, fatigue - blood test showed no adverse effects, kidney - acute kidney disease. none of the health care providers can find a solution.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine stored in unapproved storage unit
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Deep vein thrombosis, Pulmonary embolism, SARS-CoV-2 test positive
Clinical narrative: Transfered for DVT/pulmonary embolism. Tested positive with unknown symptom date.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine stored in an unapproved storage unit
Age: 9.0
Sex: F
Vaccine: HEPA, HPV9
Symptoms: Urticaria
Clinical narrative: Symptoms- Hives on abdomen , face, neck, back both arms and both legs. Treatment- Diphenhydramine 12.5mg PO given in office and RX
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine stored in an unapproved storage unit
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine stored in an unapproved storage unit
Age: 31.0
Sex: F
Vaccine: UNK
Symptoms: Myocardial infarction
Clinical narrative: Heart attack in Feb 2023
Age: 72.0
Sex: M
Vaccine: RSV
Symptoms: Atrial fibrillation
Clinical narrative: Patient received RSV (Abrysvo) vaccine on 9/2/23 at Pharmacy.   Next day after receiving the vaccine, patient called to report of potential Atrial Fibrillation the patient experienced based on the A fib sensor device reader the patient wears.  Pharmacist advised patient should follow up with his doctor or go to the emergency room.  Patients doctor advised patient to go to the emergency room, where the A Fib event the patient experienced was confirmed.  Patient was treated at the emergency room and sent home.  Patient is still concerned if he will have a repeat of the A Fib event.  Pharmacy is reporting this event.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: redness and itching at site that has continued
Age: 61.0
Sex: F
Vaccine: FLU4, RSV
Symptoms: Back pain, Dyspnoea
Clinical narrative: She got her vaccine around 11:00 AM, she did not have any reaction at first.  Her and her husband ran around all day, she was tired and she sat down.  Then on the right side on the middle of her back she was having stabbing type of darting pains that were severe in nature.  She has OA on the left side lower of her back, this was on her right side in the middle of the back on the right side.  The pain took her breathe away and she thought she would end up in the ER.  The only thing that they could think of causing the pain was the vaccine.  She has had the flu shot in the past, and she believes it was the RSV vaccine that she got.  She got up slowly, had a hernia over a year ago and has a binder, and put the binder on and then took it off to sleep and it helped.  The next morning after she slept, she had pain again on that side but not as bad.  She took Tramadol for her pain which helped, but resting on it helped.  Every so often she gets pain in the back on the right side, which she has never had that before.   She has an appointment with her PCP on 9/28/23 and is going to tell him about this.    She took the vaccine as she saw a commercial about it and due to her age she decided to get the vaccine.    She has had the COVID vaccines with no reactions.
Age: 78.0
Sex: M
Vaccine: TDAP
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: patient received a second dose of boostrix one year after his first dose. patient was not due for this vaccine. patient is not currently experiencing any signs or symptoms
Age: 86.0
Sex: M
Vaccine: RSV
Symptoms: Arthralgia, Joint swelling, Peripheral swelling, Tenderness
Clinical narrative: Patient's right elbow swelled up and was painful starting 8/27/2023. His right arm continued to swell in both directions, but mainly radiating upwards, for the next couple of days. The swelling and pain started to go down about two days ago, but is still tender
Age: 68.0
Sex: F
Vaccine: RSV
Symptoms: Fatigue, Headache, Influenza like illness, Pyrexia, Rhinorrhoea
Clinical narrative: Headache, runny nose, mild fever, skin sensitive, fatigue/tired, feel terrible-flu-like symptoms
Age: 68.0
Sex: F
Vaccine: RSV
Symptoms: Sensitive skin
Clinical narrative: Headache, runny nose, mild fever, skin sensitive, fatigue/tired, feel terrible-flu-like symptoms
Age: 58.0
Sex: M
Vaccine: RSV
Symptoms: No adverse event
Clinical narrative: no issues
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Burning sensation, Headache, Muscle spasms, Musculoskeletal stiffness
Clinical narrative: Severe headache, jaw spasms,  stiff neck & spine. It felt like my spine was on fire. Lasted x 9 days - gradually diminishing by day 9.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Covid-19 Breakthrough Infection
Age: 1.5
Sex: M
Vaccine: DTAPIPV, HEPA, HIBV, MMR, PNC15, VARCEL
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient was receiving Catch Up doses on vaccine schedule.  Patient was given Kinrix vaccine for (DTaP/IPV).  Kinrix not licensed for <4yo.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Blood test normal, Cold sweat, Computerised tomogram head normal, Head injury
Clinical narrative: Woke during the night with extreme muscular and joint pain.  Arm pain. Woke at 6:30 am with a heart rate of 120 bpm while still in bed.  Bad headache.  Came downstairs to take Tylenol for headache.  Took blood pressure which was  a little high. Broke out into a cold sweat so I sat down with head down.  Proceeded to pass out and hit my head on landing of steps and my daughter  had to call EMS.  Took me to the hospital, did bloodwork, CT scan of the head and gave fluids.  Released as per Primary Care Physician.  All tests came back normal.  Visited Dr. the next day for follow-up.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Hypertension, Loss of consciousness, Middle insomnia, Myalgia
Clinical narrative: Woke during the night with extreme muscular and joint pain.  Arm pain. Woke at 6:30 am with a heart rate of 120 bpm while still in bed.  Bad headache.  Came downstairs to take Tylenol for headache.  Took blood pressure which was  a little high. Broke out into a cold sweat so I sat down with head down.  Proceeded to pass out and hit my head on landing of steps and my daughter  had to call EMS.  Took me to the hospital, did bloodwork, CT scan of the head and gave fluids.  Released as per Primary Care Physician.  All tests came back normal.  Visited Dr. the next day for follow-up.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain in extremity, Urine analysis normal
Clinical narrative: Woke during the night with extreme muscular and joint pain.  Arm pain. Woke at 6:30 am with a heart rate of 120 bpm while still in bed.  Bad headache.  Came downstairs to take Tylenol for headache.  Took blood pressure which was  a little high. Broke out into a cold sweat so I sat down with head down.  Proceeded to pass out and hit my head on landing of steps and my daughter  had to call EMS.  Took me to the hospital, did bloodwork, CT scan of the head and gave fluids.  Released as per Primary Care Physician.  All tests came back normal.  Visited Dr. the next day for follow-up.
Age: 53.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event reported yet, we administered an expired vaccine that had been on the shelf for 27 hours at room temp
Age: 66.0
Sex: F
Vaccine: RSV
Symptoms: Diarrhoea, Fatigue, Headache, Injection site pain, Pain
Clinical narrative: Left arm pain at injection site. Diarrhea, terrible headache, body aches from head to toe, fatigue
Age: 16.0
Sex: M
Vaccine: UNK
Symptoms: Extra dose administered
Clinical narrative: pt was given MMR II on 9/1/2023 and then given Varivax on 9/5/2023 = we were not informed of the MMR until after Varivax was given.
Age: 14.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Extra dose administered
Clinical narrative: pt was given MMR II on 9/1/2023 and then given Varivax on 9/5/2023 = we were not informed of the MMR until after Varivax was given.
Age: 78.0
Sex: F
Vaccine: RSV
Symptoms: Arthralgia, Disorientation, Dizziness, Erythema, Headache
Clinical narrative: Redness and swelling on the right arm, itching on arm and pain at site of injection.  Dizziness or disoriented feeling, overall. Headache persisting since receiving vaccine (responds to acetaminophen),  Achiness in all her major joints.
Age: 78.0
Sex: F
Vaccine: RSV
Symptoms: Injection site pain, Peripheral swelling, Pruritus
Clinical narrative: Redness and swelling on the right arm, itching on arm and pain at site of injection.  Dizziness or disoriented feeling, overall. Headache persisting since receiving vaccine (responds to acetaminophen),  Achiness in all her major joints.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORED IN AN UNAPPROVED STORAGE UNIT
Age: 15.0
Sex: F
Vaccine: HEPA
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient received adult dose instead of pediatric dose
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORED IN AN UNAPPROVED STORAGE UNIT
Age: 6.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Post vaccination it was noted that the vaccine expired on 8/21/2023.  Supervisor notified, vaccine pulled from stock, clinic physician notified and consulted, parent notified.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORED IN AN UNAPPROVED STORAGE UNIT
Age: 77.0
Sex: F
Vaccine: RSV
Symptoms: Back pain, Ear pain, Eye pain, Impaired driving ability, Myalgia
Clinical narrative: arpound 3:00 i felt like a truck hit me. Every muscle ached, my neck, back. ears. eyes muscles ached for approximately 24 hours and i couldnt even drive to the emergency. I would never take this medicine again. it is 5:00 on 9/6/23 and i feel fine
Age: 77.0
Sex: F
Vaccine: RSV
Symptoms: Neck pain, Pain
Clinical narrative: arpound 3:00 i felt like a truck hit me. Every muscle ached, my neck, back. ears. eyes muscles ached for approximately 24 hours and i couldnt even drive to the emergency. I would never take this medicine again. it is 5:00 on 9/6/23 and i feel fine
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine stored in an unapproved storage unit
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORED IN AN UNAPPROVED STORAGE UNIT
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine stored in an unapproved storage unit
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccin stored in an unapproved storage unit
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine stored in an unapporved storage unit
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine stored in an unapproved storage unit
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product storage error
Clinical narrative: VACCINE WAS STORED IN AN UNAPPROVED STORAGE UNIT
Age: 11.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Pt is 11 years and 11 month old, he was given the Pfizer Bivalent Vaccine for 12 years old. No side effects or reaction reported> Patient was able to leave the pharmacy with no issue. Left a voice message on mother's phone to call back for follow up
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine stored in an unapporved storage unit
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORED IN AN UNAPPROVED STORAGE UNIT
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine stored in an unapproved storage unit
Age: 23.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine was expired as of 5/30/2023. Patient did not report any adverse symptoms.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORED IN AN UNAPPROVED STORAGE UNIT
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Post-acute COVID-19 syndrome
Clinical narrative: long covid
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORED IN AN UNAPPROVED STORAGE UNIT
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORED IN AN UNAPPROVED STORAGE UNIT
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal discomfort, Lip blister, Oral herpes, Pyrexia
Clinical narrative: PATIENT CALLED TODAY REPORTING FEVER, AND STOMACH UPSET, DRY LIPS BEGINNING SATURDAY 9/2, SUNDAY 9/3  PATIENT REPORTED FEVER BLISTERS STARTING AND THEN PROGRESSING ON BOTH TOP AND BOTTOM LIP.  I REACHED OUT TO THE PRIMARY CARE DOCTOR AND REPORTED PATIENT'S SYMPTOMS AS SHE REPORTED TO ME ON THE PHONE.  ACCORDING TO THE PATIENT, ONE OF THE DOCTORS AT HER PRIMARY CARE OFFICE CALLED IN A PRESCRIPTION FOR HER TO ANOTHER PHARMACY WHERE SHE NORMALLY GETS RXS FILLED